Optometrist · Brooklyn, NY
NPI
1477704872
Since 2008
Specialty
Optometrist
Code 152W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
586 President St Ste B
Brooklyn, NY, 11215
Phone (718) 438-5600
Groups this clinician bills Medicare through
Medicare paid, 2024
$98K
1,447 services
Medicare patients, 2024
369
Average age 74
Drug cost, 2024
$1.0M
4,264 prescriptions
Company payments, 2025
$1,746
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sally Chetrit was code 68761 (eye), 357 times for 97 patients. In total Sally Chetrit billed 1,447 services in 22 codes, and Medicare paid $98K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 68761 Eye | Office | 357 | 97 | $91.24 | $33K |
| 92014 Ophthalmological E&M | Office | 175 | 154 | $89.64 | $16K |
| 92250 Angiography | Office | 155 | 153 | $29.78 | $4,616 |
| 99214 Office E&M - Established | Office | 139 | 130 | $108.01 | $15K |
| 92012 Ophthalmological E&M | Office | 137 | 104 | $73.43 | $10K |
| 92202 Ophthalmological E&M | Office | 123 | 112 | $13.07 | $1,608 |
| 92083 Vision, Hearing, and Speech Services | Office | 94 | 90 | $47.95 | $4,507 |
| 92133 Computerized Ophthalmic Imaging | Office | 75 | 71 | $26.80 | $2,010 |
| 92134 Computerized Ophthalmic Imaging | Office | 55 | 53 | $34.30 | $1,887 |
| 92004 Ophthalmological E&M | Office | 38 | 38 | $97.53 | $3,706 |
| 99204 Office E&M - New | Office | 28 | 28 | $104.35 | $2,922 |
| 92136 Ultrasound - Nonspecific | Office | 23 | 23 | $36.01 | $828 |
| 76514 Ultrasound - Nonspecific | Office | 19 | 19 | $8.33 | $158 |
| 99212 Office E&M - Established | Office | 11 | 11 | $32.48 | $357 |
By year: 2022 $37K for 617 services; 2023 $47K for 730 services; 2024 $98K for 1,447 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sally Chetrit prescribed most often to Medicare patients was Latanoprost, with 1,062 prescriptions and refills. In total Sally Chetrit wrote 4,264 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,062 | 2,530 | 392 | $15K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 492 | 829 | 143 | $7,133 |
| Azelastine Hcl Generic | 432 | 559 | 123 | $6,473 |
| Xiidra Lifitegrast | 324 | 530 | 110 | $352K |
| Brimonidine Tartrate Generic | 215 | 466 | 72 | $34K |
| Lumigan Bimatoprost | 155 | 285 | 41 | $75K |
| Cequa Cyclosporine | 137 | 191 | 40 | $106K |
| Ketorolac Tromethamine Generic | 120 | 167 | 46 | $5,583 |
| Combigan Brimonidine Tartrate/Timolol | 120 | 200 | 35 | $50K |
| Simbrinza Brinzolamide/Brimonidine Tart | 119 | 162 | 34 | $25K |
| Restasis Cyclosporine | 117 | 187 | 35 | $107K |
| Alrex Loteprednol Etabonate | 87 | 106 | 34 | $30K |
| Timolol Maleate Generic | 83 | 162 | 23 | $1,044 |
| Prednisolone Acetate Generic | 76 | 104 | 42 | $2,961 |
| Dorzolamide Hcl Generic | 59 | 102 | 18 | $938 |
Brand drugs: 2,015 claims; generic drugs: 2,249 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sally Chetrit $1,746 ($1,746 in general payments such as food, travel and fees) from 11 companies. The largest payer was Bausch & Lomb Americas Inc. with $375.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 21 | $375 |
| Alcon Vision LLC ALC | 10 | $283 |
| Dompe US, Inc. | 6 | $234 |
| Harrow Eye, LLC | 10 | $226 |
| Abbvie Inc. ABBV | 6 | $161 |
| Genentech USA, Inc. ROG.SW | 1 | $146 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 5 | $119 |
| Tarsus Pharmaceuticals, Inc. TARS | 4 | $110 |
| Oyster Point Pharma, Inc. | 2 | $48.03 |
| Amgen Inc. AMGN | 1 | $27.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.